Characterisation of the integrin αv adhesome in human melanoma cells RPMI-7951 (CROSBI ID 678232)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa
Podaci o odgovornosti
Dekanić, Ana ; Paradžik, Mladen ; Humphries, J.D. ; Nestić, Davor ; Majhen, Dragomira ; Humphries, Martin ; Ambriović Ristov, Andreja
engleski
Characterisation of the integrin αv adhesome in human melanoma cells RPMI-7951
Integrins are transmembrane receptors often overexpressed in melanoma that can modulate response to antitumour therapy. They transmit signals from extracellular matrix (ECM) to cytoskeleton through a multimolecular complex of signalling and adaptor proteins called integrin adhesion complex (IAC). The total sum of proteins of the IAC (adhesome) represents a pool of insufficiently investigated potential targets for tumour therapy. Our previous results on human melanoma cells RPMI7951 have shown that targeted knockdown of integrin subunit αv via siRNA increased sensitivity to antitumour drugs: cisplatin, paclitaxel or vincristine, and drastically decreased in vitro migration and invasion. The goal of this study was: a) to define adhesome of RPMI7951 cells that have assembled their own ECM, b) to determine key integrins these cells use to form IACs and c) to define IAC components dependent on integrin αv in order to pinpoint proteins involved in the observed phenotype of increased sensitivity to drugs and decreased motility. IACs were isolated from RPMI7951 cells transfected with control or integrin αv specific siRNA plated on uncoated Petri dishes, upon crosslinking with DTBP and analysed by mass spectrometry. We identified 344 proteins, with a minimum number of spectra 4, in at least one of the three replicas. 31.9% of proteins are focal adhesion and 25.5% ECM associated proteins. Data suggest that RPMI7951 preferentially form IACs via integrin αvβ5. 88 proteins, whose expression was changed at least 2 times in RPMI7951 cells after integrin αv knockdown, were defined as integrin αv adhesome. These proteins might have a role in the observed phenotype of increased sensitivity to antitumour drugs and reduced motility. Further studies of IAC proteins could lead to the identification of potential target molecules for combined use with antitumour drugs for the metastatic melanoma treatment.
integrin alphav ; adhesome ; integrin adhesion complex
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
321-322.
2019.
nije evidentirano
objavljeno
10.1002/2211-5463.12675
Podaci o matičnoj publikaciji
FEBS Open Bio
Federation of European Biochemical Societies (FEBS)
2211-5463
Podaci o skupu
44th FEBS Congress ; From Molecules to Living Systems
poster
06.07.2019-11.07.2019
Kraków, Poland